Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
275.1 USD | +1.73% | +0.82% | +25.12% |
Chart calendar United Therapeutics Corporation
Upcoming events on United Therapeutics Corporation
Past events on United Therapeutics Corporation
2024-05-22 02:00 pm | American Thoracic Society Conference - Greg Lee, Tempus |
2024-05-22 02:00 pm | American Thoracic Society Conference - David Vidmar |
2024-05-22 02:00 pm | American Thoracic Society Conference - RuiJun Chen |
2024-05-22 02:00 pm | American Thoracic Society Conference - Joan A. Barberà |
2024-05-22 02:00 pm | American Thoracic Society Conference - Chad Miller |
2024-05-21 02:30 pm | American Thoracic Society Conference - Ali Ataya |
2024-05-21 02:30 pm | American Thoracic Society Conference - Steven D. Nathan |
2024-05-20 02:30 pm | American Thoracic Society Conference - Steven D. Nathan |
2024-05-19 02:30 pm | American Thoracic Society Conference - Eric Shen, PharmD |
2024-05-19 01:03 pm | American Thoracic Society Conference - Aaron B. Waxman |
2024-05-01 09:00 am | Q1 2024 Earnings Call |
2024-05-01 06:30 am | Q1 2024 Earnings Release |
2024-03-12 01:40 pm | Leerink Partners Global Biopharma Conference |
2024-03-05 12:50 pm | TD Cowen Health Care Conference |
2024-02-21 09:00 am | Q4 2023 Earnings Call |
2024-02-21 06:00 am | Q4 2023 Earnings Release |
2024-01-08 02:15 pm | JPMorgan Healthcare Conference |
2023-11-08 10:00 am | UBS BioPharma Conference - Fireside Chat |
2023-11-01 09:00 am | Q3 2023 Earnings Call |
2023-11-01 06:00 am | Q3 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 449 1 494 -3.01% | 1 483 1 460 1.57% | 1 686 1 702 -0.98% | 1 936 1 966 -1.51% | 2 328 2 292 1.57% | 2 734 |
EBITDA Million USD | Released Forecast Spread | -142 -48,8 -190.36% | 644 749 -14.08% | 606 665 -8.9% | 1 031 1 131 -8.82% | 1 238 1 221 1.38% | 1 425 |
EBIT Million USD | Released Forecast Spread | -188 -94,6 -98.31% | 594 702 -15.49% | 556 605 -8.18% | 980 1 086 -9.81% | 1 185 1 176 0.78% | 1 411 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -165 -88,9 -85.55% | 639 697 -8.34% | 594 665 -10.7% | 951 1 056 -9.99% | 1 274 1 243 2.5% | 1 536 |
Net income Million USD | Released Forecast Spread | -105 -49,6 -110.75% | 515 553 -6.83% | 476 533 -10.75% | 727 821 -11.38% | 985 978 0.69% | 1 185 |
EPS USD | Released Forecast Spread | -2,39 -1,13 -112.03% | 11,5 12,5 -7.9% | 10,1 11,4 -11.91% | 15,0 16,9 -11.4% | 19,8 19,7 0.68% | 24,5 |
Announcement Date | 26/02/20 | 24/02/21 | 24/02/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 462 420 9.97% | 467 461 1.27% | 516 493 4.57% | 492 519 -5.34% | 507 514 -1.45% | 597 524 13.8% | 609 586 4.03% | 615 576 6.74% | 678 624 8.57% | 684 | 700 | 697 | 795 | 841 |
EBITDA Million USD | Released Forecast Spread | 301 214 40.18% | 215 233 -7.77% | 327 279 17.08% | 189 291 -35.17% | 298 261 14.06% | 326 | 340 301 13.06% | 274 209 31% | 371 | |||||
EBIT Million USD | Released Forecast Spread | 288 194 48.11% | 202 235 -14.13% | 314 232 35.7% | 176 275 -36.04% | 284 277 2.5% | 313 280 12.03% | 327 309 5.69% | 260 252 3.22% | 356 336 6.11% | 366 | 372 | 341 | 502 | 504 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 309 191 61.34% | 151 238 -36.79% | 313 225 38.94% | 179 276 -35.19% | 292 279 4.79% | 335 285 17.5% | 352 318 10.6% | 295 270 9.56% | 399 358 11.24% | 402 | 408 | 352 | 545 | 547 |
Net income Million USD | Released Forecast Spread | 240 151 58.9% | 116 188 -38.2% | 239 183 30.87% | 132 221 -40.22% | 241 221 8.82% | 259 226 14.89% | 268 248 7.99% | 217 218 -0.48% | 307 281 8.98% | 310 | 315 | 282 | 431 | 432 |
EPS USD | Released Forecast Spread | 5,03 3,07 63.77% | 2,41 3,96 -39.12% | 4,91 3,77 30.25% | 2,67 4,50 -40.72% | 4,86 4,50 7.89% | 5,24 4,49 16.79% | 5,38 5,04 6.68% | 4,36 4,19 4.15% | 6,17 5,66 9.02% | 6,26 | 6,50 | 5,82 | 9,18 | 9,21 |
Announcement Date | 04/05/22 | 03/08/22 | 02/11/22 | 22/02/23 | 03/05/23 | 02/08/23 | 01/11/23 | 21/02/24 | 01/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for United Therapeutics Corporation
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- UTHR Stock
- Calendar United Therapeutics Corporation